Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NT$ 71.5
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very favourable analyst view
Data is available to registered users only
Data is available to registered users only
About
Synbio Tech, Inc. operates as a biotechnology company. It engages in the manufacturing of probiotics and related applications. The firm also offers the promotion and sale of lactic acid bacteria (LAB) drinks, human health care LAB powder, and agriculture, forestry, fishery and animal husbandry probiotics in China. The company was founded on June 1, 2000...
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, of fair va
Data is available to registered users only
Target Price
Buy
Sell